First Trust Advisors
VIR icon

First Trust Advisors’s Vir Biotechnology VIR Stock Holding History

First Trust Advisors’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,656
Closed -$92.9K – 2632
2024
Q4 		$92.9K Buy
+12,656
New +$99.8K ﹤0.01% 2529
2023
Q3 		– Sell
-132,962
Closed -$3.26M – 2497
2023
Q2 		$3.26M Sell
132,962
-108,588
-45% -$2.73M ﹤0.01% 1454
2023
Q1 		$5.62M Sell
241,550
-20,902
-8% -$535K 0.01% 1174
2022
Q4 		$6.64M Buy
262,452
+115,459
+79% +$2.83M 0.01% 1087
2022
Q3 		$2.83M Buy
146,993
+125,819
+594% +$3.2M ﹤0.01% 1501
2022
Q2 		$539K Sell
21,174
-61,536
-74% -$1.44M ﹤0.01% 2180
2022
Q1 		$2.13M Buy
82,710
+65,152
+371% +$1.93M ﹤0.01% 1757
2021
Q4 		$735K Sell
17,558
-32,814
-65% -$1.29M ﹤0.01% 2171
2021
Q3 		$2.19M Sell
50,372
-45,395
-47% -$1.97M ﹤0.01% 1738
2021
Q2 		$4.53M Buy
+95,767
New +$4.35M ﹤0.01% 1435

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return